CHD6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.102400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.953800E-01
Normal-vs-Stage2
3.617800E-02
Normal-vs-Stage3
1.362950E-01
Normal-vs-Stage4
3.042000E-01
Stage1-vs-Stage2
1.331960E-01
Stage1-vs-Stage3
1.117380E-01
Stage1-vs-Stage4
7.929200E-01
Stage2-vs-Stage3
5.102300E-03
Stage2-vs-Stage4
4.089200E-01
Stage3-vs-Stage4
1.487730E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.470200E-01
Normal-vs-AfricanAmerican
8.544300E-02
Normal-vs-Asian
5.632300E-02
Caucasian-vs-AfricanAmerican
6.774800E-01
Caucasian-vs-Asian
3.124400E-01
AfricanAmerican-vs-Asian
6.624600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.194600E-01
Normal-vs-Female
2.191800E-01
Male-vs-Female
9.303000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.620600E-01
Normal-vs-Age(41-60Yrs)
4.043800E-01
Normal-vs-Age(61-80Yrs)
1.630000E-01
Normal-vs-Age(81-100Yrs)
1.787720E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.693200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.443630E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.790800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.754200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.463200E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.961570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.870190E-02
Normal-vs-Daily Drinker
2.743400E-01
Normal-vs-Weekly Drinker
7.804700E-03
Normal-vs-Occasional Drinker
7.551400E-01
Normal-vs-Social Drinker
5.425600E-01
Non Drinker-vs-Daily Drinker
3.096800E-01
Non Drinker-vs-Weekly Drinker
7.801000E-01
Non Drinker-vs-Occasional Drinker
5.039900E-02
Non Drinker-vs-Social Drinker
1.325430E-01
Daily Drinker-vs-Weekly Drinker
2.275600E-01
Daily Drinker-vs-Occasional Drinker
2.447800E-01
Daily Drinker-vs-Social Drinker
4.914800E-01
Weekly Drinker-vs-Occasional Drinker
3.755500E-02
Weekly Drinker-vs-Social Drinker
1.011160E-01
Occasional Drinker-vs-Social Drinker
6.712400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.115200E-01
Normal-vs-Grade 2
5.557800E-02
Normal-vs-Grade 3
6.002000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.423700E-02
Grade 1-vs-Grade 3
9.355500E-02
Grade 1-vs-Grade 4
3.115200E-01
Grade 2-vs-Grade 3
5.539400E-01
Grade 2-vs-Grade 4
5.557800E-02
Grade 3-vs-Grade 4
6.002000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.403800E-02
Normal-vs-NonDiabetic
3.234000E-01
Diabetic-vs-NonDiabetic
1.009240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.677760E-01
Normal-vs-NoPancreatitis
2.457800E-01
Pancreatitis-vs-NoPancreatitis
1.022360E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.880800E-01
Normal-vs-N1
4.422100E-02
N0-vs-N1
2.957000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.901400E-01
Normal-vs-TP53-NonMutant
6.267200E-01
TP53-Mutant-vs-TP53-NonMutant
4.383800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
